{"version":"1.0","provider_name":"Brakke Consulting\u306e\u30a6\u30a7\u30d6\u30b5\u30a4\u30c8","provider_url":"https:\/\/brakkeconsulting.com\/ja","title":"News from Brakke Consulting","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"ARjEqIyQaC\"><a href=\"https:\/\/brakkeconsulting.com\/ja\/23543\/\">2000\u5e748\u670825\u65e5\u306e\u52d5\u7269\u5065\u5eb7\u30cb\u30e5\u30fc\u30b9\u3068\u30ce\u30fc\u30c8<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/brakkeconsulting.com\/ja\/23543\/embed\/#?secret=ARjEqIyQaC\" width=\"600\" height=\"338\" title=\"\u300c2000\u5e748\u670825\u65e5\u306e\u52d5\u7269\u885b\u751f\u30cb\u30e5\u30fc\u30b9\u3068\u30ce\u30fc\u30c8\u300d\u2014 Brakke Consulting\u30a6\u30a7\u30d6\u30b5\u30a4\u30c8\" data-secret=\"ARjEqIyQaC\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/brakkeconsulting.com\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>","description":"**************************************************************** Brakke Consulting&rsquo;s Animal Health News &amp; Notes for August 25, 2000 Copyright &copy; Brakke Consulting, Inc. **************************************************************** Company Earnings Releases &gt; Novartis reported sales for the first half of 2000 were CHF 514 million ($312 million), an increase of 11% over the comparable period in 1999.&nbsp; Operating income declined 30% to CHF 66 million ($40 million).&nbsp; Sales were increased by dynamic growth in the Farm Animal business in Europe, Latin America and Asia, as well as the Vericore acquisition completed in January 2000.&nbsp; These gains were offset by strong competition in the US flea and heartworm business.&nbsp; In response to the challenging environment in the US market, Novartis Animal Health has significantly increased its US sales force. (company website) &gt;&nbsp; PETsMART, Inc. announced financial results for its second fiscal quarter ended July 30, 2000. Net sales for the second quarter were $538.6 million, an increase of 4.5% over the $515.6 million reported for the same period last year, while North American comparable store sales for the quarter increased 1.2%.&nbsp; The Company reported second quarter net income of $6.5 million excluding the equity loss in PETsMART.com.&nbsp; That compares with second quarter 1999 net income of $6.6 million excluding the equity loss on PETsMART.com and the operating loss from the United Kingdom subsidiary. Including the $15.4 million of additional funding forView Full Post;"}